F-1
EX-FILING FEES
0002007702
N/A
N/A
0002007702
1
2026-03-27
2026-03-27
0002007702
2026-03-27
2026-03-27
iso4217:USD
xbrli:pure
xbrli:shares
Ex-Filing Fees
CALCULATION OF FILING FEE TABLES
F-1
CELLYAN BIOTECHNOLOGY CO., LTD
Table 1: Newly Registered and Carry Forward Securities
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Line Item Type |
|
Security Type |
|
Security Class Title |
|
Notes |
|
Fee Calculation Rule |
|
Amount Registered |
|
Proposed Maximum Offering Price Per Unit |
|
Maximum Aggregate Offering Price |
|
Fee Rate |
|
Amount of Registration Fee |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Newly Registered Securities |
| Fees to be Paid |
|
Equity |
|
Class A ordinary shares, par value US$0.001 per share |
|
(1) |
|
457(a) |
|
12,499,986 |
|
$ |
0.65 |
|
$ |
8,124,990.90 |
|
0.0001381 |
|
$ |
1,123.00 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Offering Amounts: |
|
$ |
8,124,990.90 |
|
|
|
|
1,123.00 |
| Total Fees Previously Paid: |
|
|
|
|
|
|
|
|
| Total Fee Offsets: |
|
|
|
|
|
|
|
0.00 |
| Net Fee Due: |
|
|
|
|
|
|
$ |
1,123.00 |
__________________________________________
Offering Note(s)
| (1) | |
The ordinary shares will be offered for resale by certain Selling Shareholder pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional number of ordinary shares issuable upon share splits, share dividends, or other distribution, recapitalization or similar events with respect to the ordinary shares being registered pursuant to this registration statement.
Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based on the closing price per ordinary share as reported on the Nasdaq Capital Market on March 26, 2026. |